SCHEMBL418465

SCHEMBL418465

O=C(O)CC(=O)CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27900339 0.83 EGLN1 (0.37)
SCHEMBL7673665 0.83 LDHA (0.57)
SCHEMBL8667112 0.82 CAMK2A (0.60)
SCHEMBL1924688 0.80 LDHA (0.53)
SCHEMBL21407093 0.78 GPR84 (0.64)
SCHEMBL8589697 0.78 CAMK2A (0.55)
Ethylene Glycol SCHEMBL1471647 0.78 HDAC3 (0.50)
Propanol SCHEMBL1022595 0.78 HDAC3 (0.50)
SCHEMBL9185822 0.78 LMNA (0.53)
SCHEMBL218098 0.78 PHF8 (0.65)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220220511-A1 MICROORGANISMS AND METHODS FOR PRODUCING BUTADIENE AND RELATED COMPOUNDS BY FORMATE ASSIMILATION GENOMATICA INC (US) 2022-07-14 US claimed
US-20220056488-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF AROMATICS, 2,4-PENTADIENOATE AND 1,3-BUTADIENE GENOMATICA INC (US) 2022-02-24 US claimed
US-20190264241-A1 BIOSYNTHESIS OF 1,3-BUTANEDIOL INVISTA NORTH AMERICA S.A.R.L. 2019-08-29 US claimed
EP-3218506-A1 BIOSYNTHESIS OF 1,3-BUTANEDIOL Invista Technologies S.à r.l. (CH) 2017-09-20 EP claimed
WO-2016077745-A1 BIOSYNTHESIS OF 1,3-BUTANEDIOL INVISTA TECHNOLOGIES S.A.R.L. (CH) 2016-05-19 WO claimed
US-RE39333-E1 Process for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives KANEKA CORPORATION (JP) 2006-10-10 US claimed
EP-1104750-B1 PROCESSES FOR THE PREPARATION OF 5-HYDROXY-3-OXOPENTANOIC ACID DERIVATIVES KANEKA CORP (JP) 2004-04-14 EP claimed
US-6340767-B1 REACTION OF LITHIUM AMIDE WITH ACETIC ACID ESTER AND HYDROXY PROPIONIC ACID KANEKA CORPORATION (JP) 2002-01-22 US claimed
EP-1104750-A1 PROCESSES FOR THE PREPARATION OF 5-HYDROXY-3-OXOPENTANOIC ACID DERIVATIVES KANEKA CORPORATION (JP) 2001-06-06 EP claimed
EP-4665735-A1 KRAS INHIBITORS Erasca, Inc. (US) 2025-12-24 EP disclosed
WO-2024173842-A1 KRAS INHIBITORS ERASCA, INC. (US) 2024-08-22 WO disclosed
EP-3748007-B1 GENE AUGMENTATION THERAPIES FOR INHERITED RETINAL DEGENERATION CAUSED BY MUTATIONS IN THE PRPF31 GENE MASSACHUSETTS EYE & EAR INFIRMARY (US) 2024-06-26 EP disclosed
US-20230399688-A1 COMPOSITIONS AND MULTIPLEXED SYSTEMS FOR COUPLED CELL-FREE TRANSCRIPTION-TRANSLATION AND PROTEIN SYNTHESIS AND METHODS FOR USING THEM GENOMATICA INC (US) 2023-12-14 US disclosed
CN-115615783-A Preparation method of paraffin tissue section 中南大学 2023-01-17 CN disclosed
US-6340767-B1 REACTION OF LITHIUM AMIDE WITH ACETIC ACID ESTER AND HYDROXY PROPIONIC ACID KANEKA CORPORATION (JP) 2002-01-22 US disclosed
US-6340767-B1 REACTION OF LITHIUM AMIDE WITH ACETIC ACID ESTER AND HYDROXY PROPIONIC ACID KANEKA CORPORATION (JP) 2002-01-22 US disclosed
US-6340767-B1 REACTION OF LITHIUM AMIDE WITH ACETIC ACID ESTER AND HYDROXY PROPIONIC ACID KANEKA CORPORATION (JP) 2002-01-22 US disclosed
EP-1104750-A1 PROCESSES FOR THE PREPARATION OF 5-HYDROXY-3-OXOPENTANOIC ACID DERIVATIVES KANEKA CORPORATION (JP) 2001-06-06 EP disclosed
EP-1104750-A1 PROCESSES FOR THE PREPARATION OF 5-HYDROXY-3-OXOPENTANOIC ACID DERIVATIVES KANEKA CORPORATION (JP) 2001-06-06 EP disclosed
WO-2000075099-A1 PROCESSES FOR THE PREPARATION OF 5-HYDROXY-3-OXOPENTANOIC ACID DERIVATIVES KANEKA CORPORATION (JP) 2000-12-14 WO disclosed